India Fast-Tracking Drug Regulation Overhaul, But Still Months Away
This article was originally published in PharmAsia News
India's overhaul of its drug regulation is more than three months away from being adopted, according to the Drugs Controller General of India.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.